ES8500321A1 - Procedimiento para producir un microorganismo - Google Patents

Procedimiento para producir un microorganismo

Info

Publication number
ES8500321A1
ES8500321A1 ES529360A ES529360A ES8500321A1 ES 8500321 A1 ES8500321 A1 ES 8500321A1 ES 529360 A ES529360 A ES 529360A ES 529360 A ES529360 A ES 529360A ES 8500321 A1 ES8500321 A1 ES 8500321A1
Authority
ES
Spain
Prior art keywords
interferon
arg
production
dna sequence
sequence coding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES529360A
Other languages
English (en)
Other versions
ES529360A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6164725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8500321(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES8500321A1 publication Critical patent/ES8500321A1/es
Publication of ES529360A0 publication Critical patent/ES529360A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA PRODUCIR UN MICROORGANISMO QUE CONTIENE LA INFORMACION GENETICA PARA LA BIOSINTESIS DE INTERFERON DEL TIPO BAB O DEL TIPO BBB EN UN PLASMIDO HIBRIDO.CONSISTE EN TRANSFORMAR UN MICROORGANISMO, PREFERENTEMENTE ESCHERICHIA COLI, CIN UN PLASMIDO HIBRIDO, EN EL QUE LA INFORMACION GENETICA ESTA CONTENIDA EN UNA SECUENCIA DE ADN. A CONTINUACION SE IDENTIFICAN AQUELLOS CLONES QUE CONTIENEN LA INFORMACION GENETICA PARA LA BIOSINTESIS DE LOS INTERFERONES DEL TIPO BAB O DEL TIPO BBB, CON UTILIZACION DE UN ADNC COMO SONDA DE HIBRIDACION.
ES529360A 1982-05-28 1984-02-01 Procedimiento para producir un microorganismo Granted ES529360A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823220116 DE3220116A1 (de) 1982-05-28 1982-05-28 Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES8500321A1 true ES8500321A1 (es) 1984-10-01
ES529360A0 ES529360A0 (es) 1984-10-01

Family

ID=6164725

Family Applications (2)

Application Number Title Priority Date Filing Date
ES522762A Granted ES522762A0 (es) 1982-05-28 1983-05-27 "procedimiento para la produccion simultanea de los productos geneticos de dos o mas genes afines"
ES529360A Granted ES529360A0 (es) 1982-05-28 1984-02-01 Procedimiento para producir un microorganismo

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES522762A Granted ES522762A0 (es) 1982-05-28 1983-05-27 "procedimiento para la produccion simultanea de los productos geneticos de dos o mas genes afines"

Country Status (22)

Country Link
US (1) US4820638A (es)
EP (1) EP0095702B1 (es)
JP (2) JPH0774238B2 (es)
KR (1) KR920006349B1 (es)
AT (1) ATE42114T1 (es)
AU (1) AU565479B2 (es)
DD (1) DD211359C4 (es)
DE (2) DE3220116A1 (es)
DK (1) DK164742C (es)
ES (2) ES522762A0 (es)
FI (1) FI82072C (es)
GR (1) GR79236B (es)
HK (1) HK112893A (es)
HU (1) HU196452B (es)
IL (1) IL68790A (es)
MX (1) MX9202815A (es)
NO (1) NO168538C (es)
NZ (1) NZ204384A (es)
SG (1) SG38692G (es)
SU (1) SU1346048A3 (es)
UA (1) UA8037A1 (es)
ZA (1) ZA833845B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
US4709324A (en) * 1985-11-27 1987-11-24 Motorola, Inc. Data processor control unit having an interrupt service using instruction prefetch redirection
CA2025180A1 (en) * 1989-10-12 1991-04-13 William G. Weisburg Nucleic acid probes and methods for detecting pathogenic candida yeasts
US6685933B1 (en) * 1998-07-28 2004-02-03 The United States Of America As Represented By The Department Of Health And Human Services Interferon α hybrids
BR0115392A (pt) * 2000-11-03 2004-06-15 Biomedicines Inc Método para o tratamento de uma doença sensìvel a interferona em um animal de sangue quente, método para individualizar as dosagens de uma interferona no tratamento, método para a fabricação de um dispositivo de liberação de efeito terapêutico de longa duração de uma droga ao longo de um perìodo de tempo, e conjunto útil para a ministração de uma quantidade relativamente constante de uma droga
FR2817559B1 (fr) * 2000-12-06 2003-12-12 Genodyssee Procede de determination d'un ou plusieurs polymorphisme(s) fontionnel(s) dans la sequence nucleique d'un gene "candidat" fonctionnel preselectionne et ses applications
FR2821625B1 (fr) * 2001-03-01 2003-05-16 Genodyssee Nouveaux polynucleotides comportant un polymorphisme de type snp fonctionnel dans la sequence nucleotidique du gene ifn-alpha-2 ainsi que de nouveaux polypeptides codes par ces polynucleotides et leurs utilisations therapeutiques
FR2823220B1 (fr) * 2001-04-04 2003-12-12 Genodyssee Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
US20030143197A1 (en) * 2001-11-09 2003-07-31 Moran S. Mark Method for treating diseases with omega interferon
US20040063912A1 (en) * 2002-03-15 2004-04-01 The Brigham And Women's Hospital, Inc. Central airway administration for systemic delivery of therapeutics
AU2002304965A1 (en) 2002-05-24 2003-12-12 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
ES2343518T3 (es) * 2002-09-09 2010-08-03 Hanall Biopharma Co., Ltd. Polipeptidos interferon alfa modificados resistentes a proteasas.
JP4896745B2 (ja) * 2004-02-02 2012-03-14 アンブレツクス・インコーポレイテツド 修飾されたヒトインターフェロンポリペプチドおよびこれらの使用
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
KR101106510B1 (ko) 2006-05-30 2012-01-20 인타르시아 세라퓨틱스 인코포레이티드 투피스, 내부채널 삼투압 전달 시스템 유동 조절기
MX2009001114A (es) 2006-08-09 2009-02-10 Intarcia Therapeutics Inc Sistemas de suministro osmotico y ensambles de piston.
US20080260820A1 (en) * 2007-04-19 2008-10-23 Gilles Borrelly Oral dosage formulations of protease-resistant polypeptides
RU2440097C2 (ru) 2007-04-23 2012-01-20 Интарсия Терапьютикс, Инк. Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
SI2462246T1 (en) 2009-09-28 2018-01-31 Intarcia Therapeutics, Inc. Fast-setting and / or cessation of substantially unchanged delivery of the product
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
WO2013024156A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
WO2013024158A1 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of protein kinase inhibitors and interferons or of protein kinase inhibitors and direct acting antivirals for the treatment and the prevention of hcv infection
WO2014033266A1 (en) 2012-08-31 2014-03-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti-sr-bi antibodies for the inhibition of hepatitis c virus infection
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
EP3302354B1 (en) 2015-06-03 2023-10-04 i2o Therapeutics, Inc. Implant placement systems
EP3733694A1 (en) 2016-05-16 2020-11-04 Intarcia Therapeutics, Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
MX2019008006A (es) 2017-01-03 2019-08-29 Intarcia Therapeutics Inc Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2906160A1 (de) * 1979-02-17 1980-09-04 Thomae Gmbh Dr K Verbessertes verfahren zur herstellung von humaninterferon
AU538665B2 (en) * 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
US4530901A (en) * 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
ES8308534A1 (es) * 1980-01-08 1983-09-01 Biogen Nv Un metodo de producir un polipeptido que exhibe actividad inmunologica o biologica del interferon de leucocitos humanos.
GB2068970B (en) * 1980-02-06 1983-06-22 Searle & Co Recombinant dna technique for the preparation of a protein resembling human interferon
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
ES506955A0 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
DE3106982A1 (de) * 1981-02-25 1982-09-09 Dr. Karl Thomae Gmbh, 7950 Biberach "neues tridecadeoxynukleotid, verfahren zu seiner herstellung und verwendung"
IL63327A (en) * 1981-07-16 1985-11-29 Yeda Res & Dev Production of interferon beta1 and alpha-phage recombinants for its production in host bacteria
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof

Also Published As

Publication number Publication date
FI82072B (fi) 1990-09-28
MX9202815A (es) 1992-06-30
SG38692G (en) 1992-09-04
KR840004944A (ko) 1984-10-31
HU196452B (en) 1988-11-28
EP0095702A1 (de) 1983-12-07
DE3220116A1 (de) 1983-12-01
ZA833845B (en) 1985-01-30
ATE42114T1 (de) 1989-04-15
ES8403522A1 (es) 1984-03-16
JPH0774238B2 (ja) 1995-08-09
NO168538B (no) 1991-11-25
UA8037A1 (uk) 1995-12-26
NO168538C (no) 1992-03-04
DK164742B (da) 1992-08-10
ES522762A0 (es) 1984-03-16
ES529360A0 (es) 1984-10-01
DD211359C4 (de) 1986-09-24
HK112893A (en) 1993-10-29
NZ204384A (en) 1986-11-12
JP2558422B2 (ja) 1996-11-27
AU1504483A (en) 1983-12-01
DE3220116C2 (es) 1993-02-18
DK239383A (da) 1983-11-29
KR920006349B1 (ko) 1992-08-03
FI831818L (fi) 1983-11-29
IL68790A (en) 1991-06-10
DK239383D0 (da) 1983-05-27
DE3379591D1 (en) 1989-05-18
FI82072C (fi) 1991-01-10
DK164742C (da) 1992-12-28
NO831903L (no) 1983-11-29
EP0095702B1 (de) 1989-04-12
SU1346048A3 (ru) 1987-10-15
JPS5925689A (ja) 1984-02-09
JPH0678774A (ja) 1994-03-22
IL68790A0 (en) 1983-09-30
FI831818A0 (fi) 1983-05-23
US4820638A (en) 1989-04-11
GR79236B (es) 1984-10-22
AU565479B2 (en) 1987-09-17
DD211359A5 (de) 1984-07-11

Similar Documents

Publication Publication Date Title
ES8403522A1 (es) "procedimiento para la produccion simultanea de los productos geneticos de dos o mas genes afines"
EP0034307A3 (en) Microbiologically produced polypeptide having the amino acid sequence of human interferon, dna and plasmids coding for this sequence, microorganisms containing this genetic information and process for their production
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
ES8307297A1 (es) Proceso para la produccion microbiana de interferon fibro- blasto humano
DE3177106D1 (en) Hybrid human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
CA2066370A1 (en) Yield when disulfide-bonded proteins are secreted
AU8223387A (en) Horse gamma-interferon
DE3478699D1 (en) Method for producing interferons
IL88151A (en) Interleukin-7 protein, dna sequences encoding it, its preparation and compositions containing it
EP0158892A3 (en) 59 valine insulin-like growth factor i and process for production thereof
EP0139501A3 (en) The manufacture and expression of genes for thaumatin
ES8305420A1 (es) Un procedimiento de sintesis de proinsulina humana
ATE89317T1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
EP0034306A3 (en) Microbiologically produced polypeptide having the amino acid sequence of human interferon, dna and plasmids coding for this sequence, microorganisms containing this genetic information and process for their production
ATE67243T1 (de) Verfahren zur herstellung von insulinaehnlichem wachstumsfaktor i (igf-i) und plasmid zu dessen herstellung.
ATE60802T1 (de) Mikrobiologisches verfahren zur herstellung von menschlichem lysozym.
ES8602938A1 (es) Un procedimiento para la produccion de interferon humano

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020506